Stella Pharma Corp (4888) Stock Price & News

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	108.00M	61.00M	62.00M	92.00M
Cost of goods sold	22.00M	1.00M	8.00M	13.00M
Cost of revenue	22.00M	1.00M	8.00M	13.00M
Research and development expenses	-	-	301.00M	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	233.00M	274.00M	-25.00M	324.00M
Operating expense	233.00M	274.00M	290.00M	324.00M
Total operating expenses	255.00M	275.00M	298.00M	337.00M
Operating income	-147.00M	-214.00M	-236.00M	-245.00M
Other non operating income	-2.00M	12.00M	-29.00M	20.00M
EBT including unusual items	-150.00M	-204.00M	-268.00M	-228.00M
EBT excluding unusual items	-150.00M	-204.00M	-268.00M	-228.00M
Income tax expense	1.00M	1.00M	-	-
Effective tax rate	-0.67%	-0.49%	-	-
Other operating expenses	-	-	-	-
Net income	-151.00M	-205.00M	-268.00M	-228.00M
Net profit margin	-139.81%	-336.07%	-432.26%	-247.83%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-1.00M	-2.00M	-3.00M	-3.00M
Net interest expenses	-1.00M	-2.00M	-3.00M	-3.00M
Depreciation and amortization charges	-	-	14.00M	-
EBITDA	-140.00M	-205.50M	-229.00M	-238.00M
Gain or loss from assets sale	-	-	-	-

Finance